Loading resource…
European Association for the Study of the Liver, European Association for the Study of Diabetes, European Association for the Study of Obesity
Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by steatotic liver disease in the presence of cardiometabolic risk factors without harmful alcohol intake. The guideline outlines the spectrum of MASLD, including steatosis, metabolic dysfunction-associated steatohepatitis (MASH), and related complications. It recommends case-finding strategies using non-invasive tests for individuals with cardiometabolic risk factors and provides a multi-step diagnostic process to identify those at risk of liver-related outcomes.
No account needed